Go Pro

Advisors Capital Management LLC Takes $4.07 Million Position in Synopsys, Inc. $SNPS

Synopsys logo with Technology background
Image from MarketBeat Media, LLC.

Advisors Capital Management LLC bought a new position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 9,124 shares of the semiconductor company's stock, valued at approximately $4,070,000.

Other large investors have also recently made changes to their positions in the company. Sankala Group LLC purchased a new position in Synopsys during the 4th quarter worth $25,000. Elevation Wealth Partners LLC lifted its position in shares of Synopsys by 96.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock worth $25,000 after purchasing an additional 27 shares during the period. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Synopsys in the 4th quarter worth approximately $28,000. IMG Wealth Management Inc. bought a new position in Synopsys in the second quarter worth approximately $28,000. Finally, Atlas Capital Advisors Inc. bought a new position in Synopsys in the fourth quarter worth approximately $32,000. 85.47% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the firm's stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on SNPS shares. Zacks Research raised Synopsys from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, June 30th. BNP Paribas Exane raised their price objective on Synopsys from $425.00 to $450.00 and gave the company an "underperform" rating in a research report on Thursday, May 28th. Robert W. Baird set a $558.00 target price on Synopsys in a research note on Thursday, May 28th. Benchmark reaffirmed a "buy" rating on shares of Synopsys in a research report on Wednesday. Finally, KeyCorp reiterated an "overweight" rating on shares of Synopsys in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $563.59.

Read Our Latest Report on SNPS

Synopsys Stock Down 0.0%

SNPS stock opened at $397.87 on Friday. Synopsys, Inc. has a 52 week low of $366.00 and a 52 week high of $615.79. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The firm has a 50-day simple moving average of $419.73 and a 200-day simple moving average of $440.22. The stock has a market capitalization of $76.18 billion, a P/E ratio of 92.10, a P/E/G ratio of 2.34 and a beta of 1.23.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to analysts' expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys's revenue was up 41.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines